Skip to main content

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

Publication ,  Journal Article
Breitner, JC; Wyse, BW; Anthony, JC; Welsh-Bohmer, KA; Steffens, DC; Norton, MC; Tschanz, JT; Plassman, BL; Meyer, MR; Skoog, I; Khachaturian, A
Published in: Neurology
July 22, 1999

OBJECTIVE: To examine the prevalence of Alzheimer's disease (AD) and other dementias in relation to age, education, sex, and genotype at APOE. Recent studies suggest age heterogeneity in the risk of AD associated with the APOE genotype and a possible interaction between APOE-epsilon4 and female sex as risk factors. We studied these topics in the 5,677 elderly residents of Cache County, Utah, a population known for long life expectancy and high participation rates. METHODS: We screened for dementia with a brief cognitive test and structured telephone Dementia Questionnaire, then examined all individuals with apparent cognitive symptoms and a sample of others. We estimated age-specific prevalence of AD and other dementias and used multiple logistic regression models to describe relation of AD prevalence to age, sex, education, and APOE genotype. RESULTS: We found 335 demented individuals, 230 (69%) with definite, probable, or possible AD (positive predictive value versus autopsy confirmation 85%). The adjusted prevalence estimate for AD was 6.5% and for all dementias 9.6%. After age 90, the adjusted prevalence estimate for AD was 28% and for all dementias 38%. Regression models showed strong variation in AD prevalence with age, sex, education, and number of epsilon4 alleles (effect of epsilon2 not significant). Models were improved by a term for age-squared (negative coefficient) and by separate terms for interaction of age with presence of one or two epsilon4 alleles. An association of AD with female sex was ascribable entirely to individuals with epsilon4. CONCLUSIONS: In participants with no epsilon4 alleles, the age-specific prevalence of AD reached a maximum and then declined after age 95. In epsilon4 heterozygotes a similar maximum was noted earlier at age 87, in homozygotes at age 73. Female sex was a risk factor for AD only in those with epsilon4. The epsilon4 allele accounted for 70% of the population attributable risk for AD.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Neurology

DOI

ISSN

0028-3878

Publication Date

July 22, 1999

Volume

53

Issue

2

Start / End Page

321 / 331

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Sex Distribution
  • Risk Factors
  • Prevalence
  • Predictive Value of Tests
  • Neurology & Neurosurgery
  • Mass Screening
  • Male
  • Humans
  • Genotype
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Breitner, J. C., Wyse, B. W., Anthony, J. C., Welsh-Bohmer, K. A., Steffens, D. C., Norton, M. C., … Khachaturian, A. (1999). APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology, 53(2), 321–331. https://doi.org/10.1212/wnl.53.2.321
Breitner, J. C., B. W. Wyse, J. C. Anthony, K. A. Welsh-Bohmer, D. C. Steffens, M. C. Norton, J. T. Tschanz, et al. “APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.Neurology 53, no. 2 (July 22, 1999): 321–31. https://doi.org/10.1212/wnl.53.2.321.
Breitner JC, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, Norton MC, et al. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 1999 Jul 22;53(2):321–31.
Breitner, J. C., et al. “APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.Neurology, vol. 53, no. 2, July 1999, pp. 321–31. Pubmed, doi:10.1212/wnl.53.2.321.
Breitner JC, Wyse BW, Anthony JC, Welsh-Bohmer KA, Steffens DC, Norton MC, Tschanz JT, Plassman BL, Meyer MR, Skoog I, Khachaturian A. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 1999 Jul 22;53(2):321–331.

Published In

Neurology

DOI

ISSN

0028-3878

Publication Date

July 22, 1999

Volume

53

Issue

2

Start / End Page

321 / 331

Location

United States

Related Subject Headings

  • Surveys and Questionnaires
  • Sex Distribution
  • Risk Factors
  • Prevalence
  • Predictive Value of Tests
  • Neurology & Neurosurgery
  • Mass Screening
  • Male
  • Humans
  • Genotype